Chrysophanol Exerts Anti-inflammatory Activity by Targeting Histone Deacetylase 3 Through the High Mobility Group Protein 1-Nuclear Transcription Factor-Kappa B Signaling Pathway in vivo and in vitro

Chrysophanol (Chr) is the main monomer isolated from Rheum rhabarbarum. This study aimed to identify the potential in vitro and in vivo cytoprotective effects of Chr on lipopolysaccharide (LPS)-triggered acute lung injury (ALI). We used an ALI-murine model and constructed an inflammatory macrophage...

Full description

Bibliographic Details
Main Authors: Quan Wen, Ngaikeung Lau, Huandi Weng, Peng Ye, Shaohui Du, Chun Li, Jianping Lv, Hui Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2020.623866/full
_version_ 1818930772115980288
author Quan Wen
Quan Wen
Ngaikeung Lau
Huandi Weng
Peng Ye
Shaohui Du
Chun Li
Jianping Lv
Hui Li
author_facet Quan Wen
Quan Wen
Ngaikeung Lau
Huandi Weng
Peng Ye
Shaohui Du
Chun Li
Jianping Lv
Hui Li
author_sort Quan Wen
collection DOAJ
description Chrysophanol (Chr) is the main monomer isolated from Rheum rhabarbarum. This study aimed to identify the potential in vitro and in vivo cytoprotective effects of Chr on lipopolysaccharide (LPS)-triggered acute lung injury (ALI). We used an ALI-murine model and constructed an inflammatory macrophage in vitro cell model to determine the cellular mechanisms involved in Chr-mediated activity. To observe the vital role of histone deacetylase 3 (HDAC3) in abolishing inflammation action, HDAC3 was downregulated using small interfering RNA. Analysis of the expression of nuclear transcription factor-kappa B p65 (NF-κB p65) and molecules of its downstream signaling pathway were assessed in vitro and in lung tissue samples using the mouse model. Concentrations of tumor necrosis factor-α, interleukin-1β, high mobility group protein 1 (HMGB1), and interleukin-16 in supernatants and the bronchoalveolar lavage fluid were measured using enzyme-linked immunosorbent assay. A reporter gene assay measured HMGB1 activity, and NF-κB p65 and HMGB1 intracellular localization was determined by immunofluorescence detection on histological lung samples from Chr-treated mice. The protein interactions between HMGB1, HDAC3, and NF-κB p65 were tested by co-immunoprecipitation. Chr treatment relieved LPS-induced lung lesions. Chr also enhanced superoxide dismutase levels in ALI mice. Chr reduced the LPS-induced protein expression of NF-κB and its related pathway molecules in both in vivo and in vitro models. Moreover, Chr downregulated LPS-enhanced HMGB1 expression, acetylation, and nuclear nucleocytoplasmic translocation. However, HDAC3 knockdown substantially reduced Chr-mediated HDAC3/NF-κB expression.Furthermore, Chr enhanced HMGB1/HDAC3/NF-κB p65 complex interaction, whereas HDAC3 knockdown reduced Chr-mediated HMGB1/HDAC3/NF-κB p65 formation. This study showed that the protective effects induced by Chr were associated with the regulation of the HMGB1/NF-κB pathway via HDAC3.
first_indexed 2024-12-20T04:06:00Z
format Article
id doaj.art-96620deed6934dcabf73bfe21f70b5f5
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-12-20T04:06:00Z
publishDate 2021-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-96620deed6934dcabf73bfe21f70b5f52022-12-21T19:54:02ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852021-01-01810.3389/fbioe.2020.623866623866Chrysophanol Exerts Anti-inflammatory Activity by Targeting Histone Deacetylase 3 Through the High Mobility Group Protein 1-Nuclear Transcription Factor-Kappa B Signaling Pathway in vivo and in vitroQuan Wen0Quan Wen1Ngaikeung Lau2Huandi Weng3Peng Ye4Shaohui Du5Chun Li6Jianping Lv7Hui Li8Guangdong-HongKong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, ChinaSchool of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, ChinaGuangdong Provincial Hospital of Chinese Medicine, Guangzhou, ChinaGuangdong-HongKong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, ChinaSchool of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, ChinaShenzhen Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, ChinaSchool of Nursing Sciences, Guangzhou University of Chinese Medicine, Guangzhou, ChinaDepartment of Neurosurgery, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, ChinaSchool of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, ChinaChrysophanol (Chr) is the main monomer isolated from Rheum rhabarbarum. This study aimed to identify the potential in vitro and in vivo cytoprotective effects of Chr on lipopolysaccharide (LPS)-triggered acute lung injury (ALI). We used an ALI-murine model and constructed an inflammatory macrophage in vitro cell model to determine the cellular mechanisms involved in Chr-mediated activity. To observe the vital role of histone deacetylase 3 (HDAC3) in abolishing inflammation action, HDAC3 was downregulated using small interfering RNA. Analysis of the expression of nuclear transcription factor-kappa B p65 (NF-κB p65) and molecules of its downstream signaling pathway were assessed in vitro and in lung tissue samples using the mouse model. Concentrations of tumor necrosis factor-α, interleukin-1β, high mobility group protein 1 (HMGB1), and interleukin-16 in supernatants and the bronchoalveolar lavage fluid were measured using enzyme-linked immunosorbent assay. A reporter gene assay measured HMGB1 activity, and NF-κB p65 and HMGB1 intracellular localization was determined by immunofluorescence detection on histological lung samples from Chr-treated mice. The protein interactions between HMGB1, HDAC3, and NF-κB p65 were tested by co-immunoprecipitation. Chr treatment relieved LPS-induced lung lesions. Chr also enhanced superoxide dismutase levels in ALI mice. Chr reduced the LPS-induced protein expression of NF-κB and its related pathway molecules in both in vivo and in vitro models. Moreover, Chr downregulated LPS-enhanced HMGB1 expression, acetylation, and nuclear nucleocytoplasmic translocation. However, HDAC3 knockdown substantially reduced Chr-mediated HDAC3/NF-κB expression.Furthermore, Chr enhanced HMGB1/HDAC3/NF-κB p65 complex interaction, whereas HDAC3 knockdown reduced Chr-mediated HMGB1/HDAC3/NF-κB p65 formation. This study showed that the protective effects induced by Chr were associated with the regulation of the HMGB1/NF-κB pathway via HDAC3.https://www.frontiersin.org/articles/10.3389/fbioe.2020.623866/fullchrysophanolsepsisHMGB1HDAC3NF-κB
spellingShingle Quan Wen
Quan Wen
Ngaikeung Lau
Huandi Weng
Peng Ye
Shaohui Du
Chun Li
Jianping Lv
Hui Li
Chrysophanol Exerts Anti-inflammatory Activity by Targeting Histone Deacetylase 3 Through the High Mobility Group Protein 1-Nuclear Transcription Factor-Kappa B Signaling Pathway in vivo and in vitro
Frontiers in Bioengineering and Biotechnology
chrysophanol
sepsis
HMGB1
HDAC3
NF-κB
title Chrysophanol Exerts Anti-inflammatory Activity by Targeting Histone Deacetylase 3 Through the High Mobility Group Protein 1-Nuclear Transcription Factor-Kappa B Signaling Pathway in vivo and in vitro
title_full Chrysophanol Exerts Anti-inflammatory Activity by Targeting Histone Deacetylase 3 Through the High Mobility Group Protein 1-Nuclear Transcription Factor-Kappa B Signaling Pathway in vivo and in vitro
title_fullStr Chrysophanol Exerts Anti-inflammatory Activity by Targeting Histone Deacetylase 3 Through the High Mobility Group Protein 1-Nuclear Transcription Factor-Kappa B Signaling Pathway in vivo and in vitro
title_full_unstemmed Chrysophanol Exerts Anti-inflammatory Activity by Targeting Histone Deacetylase 3 Through the High Mobility Group Protein 1-Nuclear Transcription Factor-Kappa B Signaling Pathway in vivo and in vitro
title_short Chrysophanol Exerts Anti-inflammatory Activity by Targeting Histone Deacetylase 3 Through the High Mobility Group Protein 1-Nuclear Transcription Factor-Kappa B Signaling Pathway in vivo and in vitro
title_sort chrysophanol exerts anti inflammatory activity by targeting histone deacetylase 3 through the high mobility group protein 1 nuclear transcription factor kappa b signaling pathway in vivo and in vitro
topic chrysophanol
sepsis
HMGB1
HDAC3
NF-κB
url https://www.frontiersin.org/articles/10.3389/fbioe.2020.623866/full
work_keys_str_mv AT quanwen chrysophanolexertsantiinflammatoryactivitybytargetinghistonedeacetylase3throughthehighmobilitygroupprotein1nucleartranscriptionfactorkappabsignalingpathwayinvivoandinvitro
AT quanwen chrysophanolexertsantiinflammatoryactivitybytargetinghistonedeacetylase3throughthehighmobilitygroupprotein1nucleartranscriptionfactorkappabsignalingpathwayinvivoandinvitro
AT ngaikeunglau chrysophanolexertsantiinflammatoryactivitybytargetinghistonedeacetylase3throughthehighmobilitygroupprotein1nucleartranscriptionfactorkappabsignalingpathwayinvivoandinvitro
AT huandiweng chrysophanolexertsantiinflammatoryactivitybytargetinghistonedeacetylase3throughthehighmobilitygroupprotein1nucleartranscriptionfactorkappabsignalingpathwayinvivoandinvitro
AT pengye chrysophanolexertsantiinflammatoryactivitybytargetinghistonedeacetylase3throughthehighmobilitygroupprotein1nucleartranscriptionfactorkappabsignalingpathwayinvivoandinvitro
AT shaohuidu chrysophanolexertsantiinflammatoryactivitybytargetinghistonedeacetylase3throughthehighmobilitygroupprotein1nucleartranscriptionfactorkappabsignalingpathwayinvivoandinvitro
AT chunli chrysophanolexertsantiinflammatoryactivitybytargetinghistonedeacetylase3throughthehighmobilitygroupprotein1nucleartranscriptionfactorkappabsignalingpathwayinvivoandinvitro
AT jianpinglv chrysophanolexertsantiinflammatoryactivitybytargetinghistonedeacetylase3throughthehighmobilitygroupprotein1nucleartranscriptionfactorkappabsignalingpathwayinvivoandinvitro
AT huili chrysophanolexertsantiinflammatoryactivitybytargetinghistonedeacetylase3throughthehighmobilitygroupprotein1nucleartranscriptionfactorkappabsignalingpathwayinvivoandinvitro